Compare THR & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | CVAC |
|---|---|---|
| Founded | 1954 | 2000 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2011 | 2020 |
| Metric | THR | CVAC |
|---|---|---|
| Price | $40.24 | $5.08 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.83 |
| AVG Volume (30 Days) | 358.0K | ★ 1.7M |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.04 | ★ 94.02 |
| EPS | ★ 1.75 | 0.94 |
| Revenue | ★ $509,054,000.00 | $83,000,117.00 |
| Revenue This Year | $4.87 | N/A |
| Revenue Next Year | $4.78 | $23.40 |
| P/E Ratio | $23.12 | ★ $5.39 |
| Revenue Growth | ★ 3.08 | N/A |
| 52 Week Low | $23.05 | $2.48 |
| 52 Week High | $41.20 | $5.72 |
| Indicator | THR | CVAC |
|---|---|---|
| Relative Strength Index (RSI) | 74.62 | 41.06 |
| Support Level | $38.01 | $5.05 |
| Resistance Level | $41.20 | $5.20 |
| Average True Range (ATR) | 1.47 | 0.14 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 88.05 | 20.83 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.